D.A. Davidson & Co’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$533K	Buy	36,974 +25,224	+215%	+$363K	﹤0.01%	1026
2025 Q1	$81.1K	Buy	+11,750	New	+$81.1K	﹤0.01%	1371
2022 Q1	–	Sell	-21,000	Closed	-$79K	–	1350
2021 Q4	$79K	Sell	21,000 -2,000	-9%	-$7.52K	﹤0.01%	1244
2021 Q3	$144K	Sell	23,000 -1,000	-4%	-$6.26K	﹤0.01%	1171
2021 Q2	$237K	Hold	24,000	–	–	﹤0.01%	1077
2021 Q1	$224K	Sell	24,000 -14,500	-38%	-$135K	﹤0.01%	1056
2020 Q4	$185K	Hold	38,500	–	–	﹤0.01%	970
2020 Q3	$154K	Buy	38,500 +1,500	+4%	+$6K	﹤0.01%	903
2020 Q2	$170K	Buy	37,000 +2,000	+6%	+$9.19K	﹤0.01%	879
2020 Q1	$114K	Hold	35,000	–	–	﹤0.01%	925
2019 Q4	$151K	Hold	35,000	–	–	﹤0.01%	972
2019 Q3	$138K	Hold	35,000	–	–	﹤0.01%	940
2019 Q2	$163K	Sell	35,000 -10,000	-22%	-$46.6K	﹤0.01%	921
2019 Q1	$189K	Hold	45,000	–	–	﹤0.01%	1050
2018 Q4	$154K	Hold	45,000	–	–	﹤0.01%	1013
2018 Q3	$193K	Hold	45,000	–	–	﹤0.01%	1083
2018 Q2	$167K	Buy	45,000 +1,000	+2%	+$3.71K	﹤0.01%	1044
2018 Q1	$185K	Hold	44,000	–	–	﹤0.01%	1017
2017 Q4	$259K	Buy	44,000 +1,000	+2%	+$5.89K	0.01%	905
2017 Q3	$184K	Buy	43,000 +5,000	+13%	+$21.4K	﹤0.01%	1025
2017 Q2	$145K	Hold	38,000	–	–	﹤0.01%	1099
2017 Q1	$102K	Buy	38,000 +6,000	+19%	+$16.1K	﹤0.01%	1243
2016 Q4	$105K	Sell	32,000 -10,000	-24%	-$32.8K	﹤0.01%	1284
2016 Q3	$125K	Hold	42,000	–	–	﹤0.01%	1149
2016 Q2	$173K	Buy	+42,000	New	+$173K	0.01%	893